Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Regenerative Medical Technology Group Inc.

Get SEC filing alerts via email and in your feed for Regenerative Medical Technology Group Inc.

RMTG

Regenerative Medical Technology Group Inc.

About Regenerative Medical Technology Group Inc.

Regenerative Medical Technology Group Inc. specializes in regenerative medicine, focusing on stem cell therapies, cellular products, and physician training. Through its Global Stem Cells Group and ISSCA, it provides treatments, education, and clinical solutions worldwide. The company emphasizes manufacturing, clinic network expansion, and product diversification to deliver innovative, high-quality regenerative treatments and establish industry standards in a rapidly evolving global market.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Regenerative Medical Technology Group Inc.

1
1
Regenerative Medical Technology Group Inc. Regenerative Medical Technology Group Reports 93.5% Revenue Growth but Increased Net Loss in Q1 2026

Via official filing (AI summary) | 4 days ago | 0 comments

2
1
Regenerative Medical Technology Group Inc. Regenerative Medical Technology Group Reports 24.17% Revenue Growth but Increases Net Loss to $7.8 Million

Via official filing (AI summary) | 30 days ago | 0 comments

3
1
Regenerative Medical Technology Group Inc. Regenerative Medical Technology Group Reports 19.7% Revenue Growth but Wider Net Loss in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Regenerative Medical Technology Group Inc. Regenerative Medical Technology Group Reports 24% Revenue Growth Despite Net Loss in Latest Quarter

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Regenerative Medical Technology Group Inc. Regenerative Medical Technology Group Reports 67% Revenue Growth and Plans Global Expansion

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Regenerative Medical Technology Group Inc. Meso Numismatics Reports 70.4% Revenue Growth to $4.1 Million in 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Regenerative Medical Technology Group Inc. Regenerative Medical Technology Group Reports 44.71% Revenue Growth, Net Loss Reduction in Nine Months Ended September 30, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments